Walder Wyss advised Alentis Therapeutics on the deal. Honigman advised Catalio Capital Management. Alentis Therapeutics raised $181.4 million in Series D financing, supported by a syndicate...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here